Racemic trans hydroxyiminooctahydroindolo¬2,3-a|-quinolizine...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/231, 260/272

C07D 455/00 (2006.01) A61K 31/44 (2006.01)

Patent

CA 1261336

ABSTRACT OF THE DISCLOSURE The invention relates to a process for preparing a racemic cis or trans hydroxyiminooctahydroindolo (2,3-a) quinolizine derivative of formula II or an optically active form thereof Image (II) wherein R1 and R2 are identical or different alkyl groups having from 1 to 6 carbon atoms or a pharmaceutically acceptable acid addition salt thereof, which process comprises treating a racemic cis or trans compound of formula IV Image (IV) or an optically active form thereof, wherein R2 is as defined above and R3 is an alkyl group of from 1 to 6 carbon atoms, with t-butyl nitrite in an aromatic hydrocarbon solvent followed by treatment with an alkali metal tertiary alcoholate and where required forming a pharmaceutically acceptable acid addition salt thereof, and to the compounds of formula II and their pharma- ceutically acceptable acid addition salts so formed. Compounds of formula II have pharmaceutical activity and are also useful as intermediates in the preparation of other pharmaceutical compounds.

580550

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Racemic trans hydroxyiminooctahydroindolo¬2,3-a|-quinolizine... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Racemic trans hydroxyiminooctahydroindolo¬2,3-a|-quinolizine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Racemic trans hydroxyiminooctahydroindolo¬2,3-a|-quinolizine... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1243311

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.